Residual Platelet Activity In Advanced Peripheral Artery Disease

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 410 participants.

Also called NCT01627431

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose basic science
Phase
Phase 4
Enrolled
  • 410 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01627431
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01627431. Allocation not applicable; no masking; primary purpose basic science. Start 2012-07 (registry gives no type); primary completion 2014-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Residual Platelet Activity In Advanced Peripheral Artery Disease
Acronym
TRAIANO
Condition
Peripheral Arterial Disease
Intervention (Drug)
Acetylsalicylic acid
Intervention (Drug)
Clopidogrel
Lead sponsor
University of Roma La Sapienza (class: other)
Collaborator
University of Florence (class: other)

Record details

Record id
cardio:ct-nct01627431
Content hash
80b412227f162f9659824fc743a2c63804d50c0eb809077576c2f2e84c0ba402